Skip to main content
. 2006 Jan 25;2006(1):CD005593. doi: 10.1002/14651858.CD005593

1.32. Analysis.

1.32

Comparison 1 Cholinesterase inhibitor (optimum dose) vs placebo, Outcome 32 Number who suffered at least one adverse event of fracture before end of treatment at 6 months or later.